Enter assignee name

EPO Patents = 1

Forward Citations = 4

Loading Chart...

6 inventors (with patents filed for the assignee):

Oren Becker (7 out of 27 patents)

Vered Behar (6 out of 9 patents)

Reut Yosef Hamo (5 out of 5 patents)

4. Eyal Dor-On (3 out of 4 patents)

5. Paul Salama (2 out of 13 patents)

6. Hadas Tamar Pahima (2 out of 2 patents)

7. Chaim Mann Brickman (0 patent)

7 patents: Sort by Forward Citations

1. 12527782 - Use of hexokinase 2/mitochondria-detaching compounds for treating hexokinase-2 (HK2)-expressing cancers (2026-01-20),

2. 12162868 - Piperazine derivatives, pharmaceutical compositions and methods of use thereof (2024-12-10),

3. 12083111 - Use of hexokinase 2/mitochondria-detaching compounds for activating immune responses (2024-09-10),

4. 11905250 - Methods for preparation of jasmonate compounds (2024-02-20),

5. 11266639 - Use of hexokinase 2/mitochondria-detaching compounds for treating hexokinase-2 (HK2)-expressing cancers (2022-03-08),

6. 11096935 - Use of hexokinase 2/mitochondria-detaching compounds for activating immune responses (2021-08-24),

7. 10682346 - Use of hexokinase 2/mitochondria-detaching compounds for activating immune responses (2020-06-16),

Vidac Pharma Ltd. is a clinical-stage biotechnology company focused on discovering and developing innovative drugs for the treatment of cancer and rare genetic diseases. Their lead product candidate, VDA-1102, has shown promising results in preclinical studies and is currently being evaluated in clinical trials. With a commitment to improving patient outcomes and addressing unmet medical needs, Vidac Pharma is dedicated to advancing cutting-edge therapies that have the potential to make a significant impact on the lives of patients.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

7 Patents

#14 in Ness Ziona

#910 in Israel

Ness Ziona, Israel

Vidac Pharma Ltd.